XENE — Xenon Pharmaceuticals Inc.
Healthcare · ETF XLV · as of 2026-07-20
Daily · EMA 10 / 20 / 50 · SMA 200 · VolPress: buy/sell split, 20-SMA, white dot = above avg · · RS vs SPY ⓘ our data
Xenon Pharmaceuticals Inc.
NGM
Healthcare · Biotechnology
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.
Fundamentals & valuation - reference, not entry inputs
P/E (TTM)
-
Fwd P/E
-
PEG
-
Price/Book
7.9
Profit margin
0.0%
ROE
-51.8%
Debt/Equity
1.4
Rev growth
-
Analyst target
$79 (+20%)
Analyst rating
STRONG_BUY
Institutional %
94.8%
Insider %
0.1%
Float %
81.1%
Valuation and analyst figures are Yahoo company stats (weekly refresh, ~3,000 larger names - blanks are honest gaps); logo, employees, website and IPO date are Massive company reference. Momentum/VCP entries do not use valuation - this card is context so you do not have to leave the page.
MarketSmith metrics - our compute
RS Rating
95.3
ADR%
4.2
RMV (tight)
35.0
Ext (ATR>20EMA)
0.9
Rel Vol
45.0%
U/D Ratio
1.4
EPS YoY
-42.0%
LoD dist
3.0
Off 52w High
9.1%
Above 52w Low
120.1%
1W / 1M
-2.5 / +24.1
Avg $Vol 50d
90.3M
Mkt Cap (B)
6.4
Trend 8/8
YES
Leads Group
YES
Sector XLV
-1.3% 1W
Base len (VCP)
19wk (7/20)
not available: vol_buzz(formula TODO from swing-data.txt)
What do these abbreviations mean?
- RS Rating
- - IBD-style relative strength vs SPY (weighted 3/6/9/12-mo). 70+ = leaders pool, 80+ = strong.
- ADR%
- - average daily range over 20 days. 4%+ = the fast movers the playbook prefers (selection order, not a gate).
- RMV (tight)
- - Relative Measured Volatility, 15 bars, scaled 0-100. <15 = tight coiled base (green), <35 moderate, high = loose/expanding - not a base right now.
- Ext (ATR>20EMA)
- - how many ATRs price sits above its 20-EMA. ≤1 = in value (green), >2 = extended/chasing (red) - prefer a pullback.
- Rel Vol
- - latest volume vs the 50-day average. 100% = normal; 140%+ = breakout confirmation.
- U/D Ratio
- - up-day vs down-day volume, 50 days. 1.1+ = net accumulation.
- LoD dist
- - close distance above the day low in % of ATR (100 = one full ATR off the low). High = strong close.
- Off/Above 52w
- - trend-template legs: within 25% of the 52-week high, at least 25% above the 52-week low.
- Trend 8/8
- - all 8 Minervini Trend Template criteria pass. Discovery floor, NOT an entry signal - entries come from the VCP/momentum pivots.
- Base len (VCP)
- - weeks since the VCP base started on the latest scan. 10wk+ bases carry the edge; short stacked bases test below random.
Company data - context read, not entry inputs
Industry rank
115 / 131
Industry
Biotechnology
Float
78.4M
Float turnover 20d
2.5%
Avg $Vol 20d / 50d
124.0M / 90.3M
Days to cover
4.1
Short % float
5.0%
Institutional %
94.8%
Weinstein stage
2
Float, short interest and institutional % come from Yahoo company stats, refreshed weekly for ~3,000 larger names - a blank means Yahoo does not publish the figure for this stock, not that it is zero. Dollar volume and float turnover are computed from our own price bars; industry rank from our rotation data; stage from the weekly chart.
Quarterly EPS - earnings acceleration
| Quarter | EPS ($) | %Chg YoY | Sales ($M) | %Chg |
|---|---|---|---|---|
| Feb-24 | -0.64 | - | - | - |
| May-24 | -0.62 | - | - | - |
| Aug-24 | -0.75 | - | - | - |
| Nov-24 | -0.81 | - | - | - |
| Feb-25 | -0.84 | - | - | - |
| May-25 | -0.83 | - | - | - |
| Aug-25 | -1.07 | - | - | - |
| Nov-25 | -1.15 | - | - | - |
EPS = Yahoo adjusted, matches MarketSmith/Deepvue - NOT TradingView's GAAP · Sales ($M) = SEC EDGAR quarterly revenue (fiscal Q4 derived as FY minus 9-mo) · quarter = report month · %Chg blank = prior-year base under $0.05 (not meaningful).
Price & today
$66.04
ATR(14) 2.52 (3.81%)
| Stock today | -3.25% |
| Sector ETF today | -1.14% |
| Residual (stock-specific) | -2.11% |
Sector correlation
| 20-day correlation with XLV | 0.18 |
| 60-day correlation with XLV | 0.21 |
| Status | normal |
Decoupling fires when 60d corr − 20d corr > 0.20: stock used to track its sector but the relationship has weakened recently.
Technicals
| 10 EMA | $66.30 |
| 20 EMA | $63.66 |
| 50 EMA | $59.34 |
| EMA stack | BULLISH |
| RSI(14) | 61.6 |
| 52-week high distance | +3.27% |
| 52-week low distance | +134.27% |
Signals
| Market F&G | 57.3 |
| Bull% | 31.0% |
| OVTLYR status | BUY (117d) |
| Sector rank | #335 |
| Next earnings | 2026-08-10 (AMC, 20d) |